{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:37:14Z","timestamp":1772109434301,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Interventional Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jimed.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T10:34:30Z","timestamp":1597574070000},"page":"174-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of two different glycoprotein platelet IIb\/IIIa inhibitors and the clinical endpoints in patients with intracranial Pipeline flow diverter implant"],"prefix":"10.1016","volume":"3","author":[{"given":"Qiao","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jimed.2020.08.005_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging","volume":"378","author":"Albers","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jimed.2020.08.005_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A\u00a0randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jimed.2020.08.005_bib3","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3174\/ajnr.A5388","article-title":"Treatment of middle cerebral artery aneurysms with flow-diverter stents: a systematic review and meta-analysis","volume":"38","author":"Cagnazzo","year":"2017","journal-title":"AJNR"},{"key":"10.1016\/j.jimed.2020.08.005_bib4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/STROKEAHA.113.001059","article-title":"Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial","volume":"44","author":"Pancioli","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jimed.2020.08.005_bib5","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/STROKEAHA.116.015308","article-title":"Use of platelet function testing before pipeline embolization device placement: a multicenter cohort study","volume":"48","author":"Adeeb","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jimed.2020.08.005_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clineuro.2017.08.003","article-title":"Flow diversion with the pipeline embolization device forpatients with intracranial aneurysms and antiplatelet therapy: a systematic literature review","volume":"161","author":"Texakalidis","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jimed.2020.08.005_bib7","first-page":"1932","article-title":"Placement of a stent within a flow diverter improves aneurysm occlusion rates","volume":"40","author":"Ocal","year":"2019","journal-title":"AJNR"},{"key":"10.1016\/j.jimed.2020.08.005_bib8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3171\/2018.7.JNS18654","article-title":"Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: complications, aneurysm sac occlusion, reabsorption, recurrence, and jailed branch modification at follow-up","volume":"131","author":"Michelozzi","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jimed.2020.08.005_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0003319718808911","article-title":"Effects of bailout tirofiban on in-hospital outcomes and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention","volume":"70","author":"Velibey","year":"2019","journal-title":"Angiology"},{"key":"10.1016\/j.jimed.2020.08.005_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40256-018-0305-0","article-title":"ATLANTIC Investigators. Morphine and ticagrelor interaction in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: ATLANTIC-morphine","volume":"19","author":"Lapostolle","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jimed.2020.08.005_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jimed.2020.08.005_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/eurheartj\/ehp376","article-title":"Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials","volume":"31","author":"Valgimigli","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jimed.2020.08.005_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2018.09.052","article-title":"Safety and efficacy of tirofiban in STEMI-patients","volume":"274","author":"Dannenberg","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jimed.2020.08.005_bib14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Andomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jimed.2020.08.005_bib15","first-page":"929","article-title":"Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques","volume":"117","author":"Rossen","year":"2012","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jimed.2020.08.005_bib16","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial","volume":"385","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jimed.2020.08.005_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/STROKEAHA.116.015414","article-title":"Is unexplained early neurological deterioration after intravenous thrombolysis associated with thrombus extension]","volume":"48","author":"Seners","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jimed.2020.08.005_bib18","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/STROKEAHA.119.026240","article-title":"Low-dose tirofiban treatment improves neurological deterioration outcome after intravenous thrombolysis","volume":"50","author":"Wu","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jimed.2020.08.005_bib19","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jimed.2020.08.005_bib20","first-page":"1751","article-title":"Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: complications, aneurysm sac occlusion, reabsorption, recurrence, and jailed branch modification at follow-up","volume":"131","author":"Michelozzi","year":"2019","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jimed.2020.08.005_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH15-02-0180","article-title":"Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI: the result of the TE-CLOT trial","volume":"115","author":"Kim","year":"2016","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jimed.2020.08.005_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2008.09.060","article-title":"Abbreviated infusion of eptifibatide after successful coronary intervention. The BRIEF-PCI (brief infusion of eptifibatide following percutaneous coronary intervention) randomized trial","volume":"53","author":"Fung","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jimed.2020.08.005_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3174\/ajnr.A4191","article-title":"Extra-aneurysmal flow modification following pipeline embolization device implantation: focus on regional branches, perforators, and the parent vessel","volume":"36","author":"Gascou","year":"2015","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.jimed.2020.08.005_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2459\/JCM.0b013e32833cdd04","article-title":"Long-term efficacy of high-dose tirofiban versus double-bolus eptifibatide in patients undergoing percutaneous coronary intervention","volume":"12","author":"Schiariti","year":"2011","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.jimed.2020.08.005_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/1755-5922.12203","article-title":"A\u00a0randomized trial assessing the impact of three different glycoprotein IIb\/IIIa antagonists on glycoprotein IIb\/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes","volume":"34","author":"Holmes","year":"2016","journal-title":"Cardiovasc Ther."}],"container-title":["Journal of Interventional Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2096360220300533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2096360220300533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:07:48Z","timestamp":1761869268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2096360220300533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2096360220300533"],"URL":"https:\/\/doi.org\/10.1016\/j.jimed.2020.08.005","relation":{},"ISSN":["2096-3602"],"issn-type":[{"value":"2096-3602","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of two different glycoprotein platelet IIb\/IIIa inhibitors and the clinical endpoints in patients with intracranial Pipeline flow diverter implant","name":"articletitle","label":"Article Title"},{"value":"Journal of Interventional Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jimed.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Shanghai Journal of Interventional Medicine Press. Production and hosting by Elsevier B.V. on behalf of KeAi.","name":"copyright","label":"Copyright"}]}}